Company Search:
Advanced Search
Sponsored Links
Ipsen SA Company Snapshot
Ipsen SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ipsen SA with three other companies in this sector in France: Boiron SA (2017 sales of 617.54 million Euro [US$729.09 million] of which 50% was Non-Proprietary Homeopathic Medicines), Virbac (861.88 million Euro [US$1.02 billion] of which 55% was Companion Animals), and Guerbet SA (807.12 million Euro [US$952.92 million] of which 47% was X-rays).

Sales Analysis. Ipsen SA reported sales of 2.01 billion Euro (US$2.38 billion) for the year ending December of 2017. This represents an increase of 20.4% versus 2016, when the company's sales were 1.67 billion Euro. Sales at Ipsen SA have increased during each of the previous five years (and since 2012, sales have increased a total of 57%). Sales of Specialty Care saw an increase of 25.1% in 2017, from 1.27 billion Euro to 1.59 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ipsen SA
  Stock Performance Chart for Ipsen SA
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 133.70
(Figures in Euro)
1 Week 2.9%   13 Weeks 5.0%  
4 Weeks 11.4%   52 Weeks 21.7%  
Ipsen SA Key Data:
  Ticker: IPN Country: France
  Exchanges: FRA LON PAR OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,011,800,000
(Year Ending Jan 2018).
Employees: 5,401
  Currency: Euro Market Cap: 11,039,954,080
  Fiscal Yr Ends: December Shares Outstanding: 82,572,581
  Share Type: Action Ordinaries Closely Held Shares: 47,659,783
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.